The hazards of dual renin-angiotensin blockade in chronic kidney disease.
Ku E, Park J, Vidhun J, Campese V. Arch Intern Med. 2009 Jun 8;169(11):1015-8
This paper reviews the pertinent literature that addresses dual RAS blockade in CKD and concludes that the simultaneous use of ACE inhibitors and ARBs should be discouraged in primary care.
Related Articles:
- Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?
- Prevention in Renal Disease Conference 2009
- Proteinuria: Is the ONTARGET renal substudy actually off target?
Recent Comments